CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Coherus Biosciences, Inc.  (CHRS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

CHRS's Revenue Year on Year Growth by Quarter and Year

Coherus Biosciences,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
CHRS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 162.84 7.17 16.05
III Quarter September - 14.07 6.87 0.00
II Quarter June - 12.36 5.81 0.00
I Quarter March 0.16 10.20 -46.09 0.00
FY   0.16 199.47 -26.24 16.05

Financial Statements
Coherus Biosciences,'s first quarter 2017 Revenue $ 0.16 millions CHRS's Income Statement
Coherus Biosciences,'s first quarter 2016 Revenue $ 10.20 millions Quarterly CHRS's Income Statement
CHRS's Growth by Division See CHRS's Growth by Segment

CHRS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 2171.13 % -55.33 % -
III Quarter September - 104.8 % - -
II Quarter June - 112.74 % - -
I Quarter March -98.42 % - - -
FY   - - - -



CHRS Revenue Growth Comment
Coherus Biosciences, Inc. reported drop in Revenue in the first quarter by -98.42% to $ 0.16 millions, from the same quarter in 2016.
The fall in the first quarter Coherus Biosciences, Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 447.12%.

Looking into first quarter results within Biotechnology & Drugs industry 101 other companies have achieved higher Revenue growth. While Coherus Biosciences, Inc.' s Revenue drop of -98.42% ranks overall at the positon no. 4111 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #102
Healthcare Sector #520
Overall #4111
Revenue Y/Y Growth Statistics
High Average Low
2172.01 % 447.12 % -98.7 %
(Sep 30 2016)   (Mar 31 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CHRS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CHRS's Competitors
Revenue Growth for Coherus Biosciences,'s Suppliers
Revenue Growth for CHRS's Customers

You may also want to know
CHRS's Annual Growth Rates CHRS's Profitability Ratios CHRS's Asset Turnover Ratio CHRS's Dividend Growth
CHRS's Roe CHRS's Valuation Ratios CHRS's Financial Strength Ratios CHRS's Dividend Payout Ratio
CHRS's Roa CHRS's Inventory Turnover Ratio CHRS's Growth Rates CHRS's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Utah Medical Products Inc -0.41 %$ -0.408 millions
Livanova Plc -0.65 %$ -0.650 millions
Tearlab Corp -0.98 %$ -0.975 millions
Parexel International Corp -1.01 %$ -1.014 millions
Alliqua Biomedical, Inc. -1.06 %$ -1.055 millions
Spark Therapeutics, Inc. -1.10 %$ -1.099 millions
Amgen Inc. -1.14 %$ -1.140 millions
Zynex Inc -1.18 %$ -1.179 millions
Biolase, Inc -1.24 %$ -1.235 millions
Ligand Pharmaceuticals Inc -1.29 %$ -1.285 millions
Seattle Genetics Inc -1.82 %$ -1.821 millions
Reliv International Inc -1.98 %$ -1.984 millions
Adaptimmune Therapeutics Plc -2.09 %$ -2.090 millions
Wright Medical Group N.v. -2.12 %$ -2.119 millions
Oncomed Pharmaceuticals Inc -2.16 %$ -2.157 millions
Prothena Corp Plc -2.26 %$ -2.264 millions
Antares Pharma, Inc. -2.53 %$ -2.527 millions
Integrated Biopharma Inc -2.89 %$ -2.889 millions
Allied Healthcare Products Inc -2.93 %$ -2.930 millions
Becton Dickinson & Co -3.20 %$ -3.195 millions
Encision Inc -3.36 %$ -3.361 millions
Infusystem Holdings, Inc -3.50 %$ -3.498 millions
Brookdale Senior Living Inc. -3.67 %$ -3.673 millions
Kindred Healthcare, Inc -3.79 %$ -3.785 millions
Tenet Healthcare Corp -4.13 %$ -4.133 millions
Chembio Diagnostics, Inc. -4.18 %$ -4.180 millions
Progenics Pharmaceuticals Inc -4.20 %$ -4.204 millions
Cas Medical Systems Inc -4.23 %$ -4.228 millions
Amphastar Pharmaceuticals, Inc. -4.54 %$ -4.541 millions
Strata Skin Sciences, Inc. -4.57 %$ -4.567 millions